DOC Search
Designed for:
  • Life Science companies
  • Disease researchers
  • Academic organizations
  • Healthcare providers
Learn More
Designed for:
  • Medical Professional Societies
  • Healthcare Providers
  • Evidence-based Practice Centers
  • Guideline Panels
Learn More
Designed for:
  • Academic Research Centers
  • Health and Hospital Systems
  • Evidence-based Practice Centers
  • Practice-based Research Networks
Learn More

EBM and Public Policy: Obstacles and Opportunities in Congress

By Tom Allen | December 17, 2018

  By Tom Allen Former member of the United States House of Representatives (D-ME) Background I represented Maine’s first Congressional District…

Read More

NEWS : Doctor Evidence CEO Awarded Two Honorary Fellowships Robert Battista was recently selected for fellowship in the Royal College of Physicians of Edinburgh and the Royal Society for Public Health.

SANTA MONICA, Calif.Nov. 27, 2018 /PRNewswire/ -- Doctor Evidence announces the awarding of two honorary fellowships to Robert Battista, the CEO and co-founder, in recognition for his innovative work in healthcare. The Royal College of Physicians of Edinburgh and the Royal Society for Public Health have conferred these honors on Mr. Battista following nominations from and voting by their respective memberships. He was elected to fellowship in recognition of his substantive contributions to the medical community and career commitment to the improvement of healthcare, particularly uniting otherwise disparate communities in the ecosystem to collaborate for better patient wellbeing.

NEWS : Doctor Evidence Conducted Systematic Evidence Review for Leading Cardiology Societies for Bradycardia Guideline Evidence Review and Analyses

SANTA MONICA, Calif.Nov. 6, 2018 /PRNewswire/ -- Today, the American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society (HRS) published guidelines on the diagnosis and treatment of bradycardia, an abnormally slow heart rate, along with the supporting systematic review. The 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay were simultaneously published in Circulation, the Journal of the American College of Cardiology (JACC)and HeartRhythm. An Executive Summary was also published in all three journals: CirculationJACC, and HeartRhythm.

NEWS : Connecting Published Data To Real World Evidence: What's The DIF (Data Impact Factor)

SANTA MONICA, Calif.Nov. 5, 2018 /PRNewswire/ -- Doctor Evidence has launched DIF—the Data Impact Factor—technology for identifying data cohorts, across time and various reported data sets.  As technology progresses, it has become possible to move from past paradigms, like the Journal Impact Factor, which is an index of the relative influence of leading journals. Today's innovative technologies can assign actual weights, prominence, and influence factors to individual data cohorts across all research or within a selected topic area.  DIF embraces the increased capabilities for micro-tagging of clinical trial research and subsequent representations of that data.

NEWS : The American Society Of Hematology To Make Its Meeting Abstracts Available In Leading Artificial Intelligence Technology Platform

WASHINGTONOct. 26, 2018 /PRNewswire/ -- The American Society of Hematology (ASH), has entered into an agreement with Doctor Evidence (DRE) to host ASH annual meeting abstracts in DRE's innovative DOC Search artificial intelligence technology platform. ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.

NEWS : American Thoracic Society publishes guideline on malignant pleural effusions; Doctor Evidence collaborated on the underlying meta-analysis

New Guideline Recommends Minimally Invasive Ways of Treating Malignant Pleural Effusions

Oct. 1, 2018─A new guideline to help clinicians manage malignant pleural effusions (MPEs) has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology.  The clinical practice guideline is published online in the Oct. 1 American Journal of Respiratory and Critical Care Medicine.


SANTA MONICA, Calif.Feb. 14, 2018 /PRNewswire/ -- Doctor Evidence (DRE), a global health technology and data company, is proud to have performed the systematic review of evidence, through the GROWTH program, in support of a new guideline issued by the American Society of Clinical Oncology, Inc. (ASCO®), the world's leading professional organization representing physicians who care for people with cancer, in collaboration with the National Comprehensive Cancer Network® (NCCN®). The organizations collaborated to develop comprehensive guidelines to help clinicians with optimal strategies for the identification and diagnosis of adverse events associated with immune checkpoint inhibitors and to offer guidance on their safe management.

The Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guidelinepublished online on February 14, 2018 at 10 AM Eastern in the Journal of Clinical Oncology (JCO)and the ASCO website.


SANTA MONICA, Calif.Jan. 29, 2018 /PRNewswire/ -- Today, the highly anticipated guidelines on screening for lung cancer by the American College of Chest Physicians® (CHEST) were published online on the journal CHEST® website. This comes after the guideline panelists provided a peek at the recommendations during the CHEST annual meeting in October in TorontoDoctor Evidence (DRE), a global health technology and consulting company, was selected to perform the systematic review of evidence in support of this guideline, through the GROWTH program.


The American Heart Association/American Stroke Association 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke were published Wednesday, January 24, along with the Systematic Review, conducted by Doctor Evidence (in association with the Evidence Review Committee).

Stay up to date with the evolving science of evidence-based medicine (EBM) with GROWTH Commentaries, a series of monthly open-access essays written by well-known experts in the field. GROWTH Commentaries represent high-quality research and new developments in the practice of EBM and provide insights from thought-leaders in the design and methods of informed clinical decisions based on solid data and trusted processes.

EBM and Public Policy: Obstacles and Opportunities in Congress

December 17, 2018

  By Tom Allen Former member of the United States House of Representatives (D-ME) Background I represented Maine’s first Congressional District…

Read More

Understanding How Health Systems View the Pros and Cons of Different Evidence Types

November 19, 2018

By C. Michael White, PharmD, Professor & Head of Pharmacy Practice, University of Connecticut School of Pharmacy, and Co-Director, University…

Read More

New Opportunities for Evidence-Based Policymaking in Health Care

October 21, 2018

By Sherry Glied, MS, PhD Dean, NYU Wagner Graduate School of Public Service Member, Commission on Evidence-Based Policymaking Introduction Last…

Read More

The Problem with Gun Violence Research: Fear of Uncomfortable Answers

September 20, 2018

By Alan I. Leshner, MS, PhD CEO Emeritus, American Association for the Advancement of Science Introduction The purpose of science…

Read More

Making Peace with My Friend Jay Dickey

August 20, 2018

By Mark Rosenberg, MD, MPP President Emeritus, The Task Force for Global Health Introduction I went to graduate school in…

Read More

Real-World Evidence to Increase Value in Health Care

July 20, 2018

By Mark McClellan, MD, PhD, Director of the Duke Margolis Center for Health Policy and the Robert J. Margolis, MD, Professor…

Read More

The Opacity of Transparency: The Search for a Cure to Our Health Care Woes

June 19, 2018

By Niall Brennan, MPP President & CEO, Health Care Cost Institute Introduction Health care spending is exceedingly difficult to control…

Read More

Why Evidence Matters for Universal Health Coverage: A Perspective from the World Bank Group

May 18, 2018

By Timothy G. Evans, MD, PhD Senior Director, Health, Nutrition, and Population Global Practice The World Bank Introduction Evidence is…

Read More

Contemporary Health Policymaking: Where’s the Evidence?

April 19, 2018

By Susan Dentzer President and CEO, Network for Excellence in Health Innovation (NEHI) Former senior policy adviser for the Robert…

Read More

Designing a New Medical School for the 21st Century: Kaiser Permanente School of Medicine

March 19, 2018

By Craig W Robbins, MD, MPH Medical Director, Kaiser Permanente Care Management Institute—Center for Clinical Information Services & Education Member,…

Read More

Don't know where to start?...

Our team will be happy to help you.